Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“MedCity is invaluable among the many sources of industry reporting because the team endeavor to bring the truly new, and innovative opportunities and developments to light.”

Ken Kirby, President, Transdermal Delivery Solutions Corp


Sign up for our daily newsletter


Russia rejects Abbott Laboratories’ plan to buy Petrovax

April 19, 2013 8:00 am by | 0 Comments

MOSCOW (Reuters) - Russia's government commission on foreign investment has rejected U.S. Abbott Laboratories' plan to buy Russian pharmaceutical producer Petrovax, the head of the Russian antitrust regulator said on Friday.

"The commission has reviewed the question about the sale to U.S. company Abbott of Petrovax Pharm. As a result of very lengthy discussion the U.S. company was denied to make this deal," Igor Artemyev, head of the Federal Anti-Monopoly Service (FAS), told reporters.

Abbott Laboratories filed for permission to buy the Russian vaccine developer and producer last year.

Abbott Laboratories spokeswoman Irina Gushchina said the company had not received any official information regarding the state of its application.

Advertisement

(Reporting by Darya Korsunskaya; Writing by Maria Kiselyova; Editing by Megan Davies)

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
0 comments